| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 140.26B | 136.30B | 128.74B | 115.48B | 104.02B | 84.72B |
| Gross Profit | 34.90B | 32.17B | 31.30B | 26.17B | 26.76B | 19.52B |
| EBITDA | 20.15B | 18.79B | 16.46B | 12.77B | 15.01B | 11.65B |
| Net Income | 3.71B | 2.72B | 2.57B | -2.21B | 1.90B | 104.00M |
Balance Sheet | ||||||
| Total Assets | 203.84B | 196.66B | 188.37B | 173.32B | 166.16B | 155.18B |
| Cash, Cash Equivalents and Short-Term Investments | 29.38B | 29.15B | 30.96B | 24.11B | 23.02B | 22.01B |
| Total Debt | 68.24B | 65.79B | 63.38B | 61.93B | 57.13B | 58.47B |
| Total Liabilities | 118.19B | 114.56B | 109.64B | 102.86B | 97.45B | 90.63B |
| Stockholders Equity | 76.19B | 72.75B | 68.82B | 61.14B | 60.34B | 56.39B |
Cash Flow | ||||||
| Free Cash Flow | 3.33B | 342.00M | 8.67B | -162.00M | 6.27B | 1.84B |
| Operating Cash Flow | 12.54B | 10.92B | 16.66B | 5.00B | 13.21B | 10.10B |
| Investing Cash Flow | -6.49B | -8.39B | -8.30B | -6.34B | -8.07B | -7.04B |
| Financing Cash Flow | -2.21B | -2.39B | -2.50B | 790.00M | -5.08B | -3.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥78.94B | 7.82 | ― | 4.95% | -5.89% | 8.95% | |
79 Outperform | ¥75.98B | 7.83 | 5.20% | 3.67% | -3.78% | -16.61% | |
74 Outperform | ¥156.41B | 13.70 | ― | 4.47% | 2.01% | 25.09% | |
71 Outperform | ¥164.88B | -8.32 | ― | 1.93% | -3.23% | 24.93% | |
69 Neutral | ¥209.62B | 10.65 | 7.50% | 5.39% | -2.26% | ― | |
65 Neutral | ¥40.48B | 14.81 | 5.33% | 2.09% | 1.26% | 56.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |